BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND TIMP1, CLGI, EPA, EPO, HCI, TIMP, TIMP-1 AND Diagnosis
17 results:

  • 1. [Screening of differentially expressed genes in gastric cancer based on GEO database and function and pathway enrichment analysis].
    Liang Y; Lai Y; Yuan Y; Yuan W; Zhang X; Zhang B; Lu Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 Mar; 44(3):605-616. PubMed ID: 38597453
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Five hub genes contributing to the oncogenesis and trastuzumab-resistance in gastric cancer.
    Chen F; Wang Y; Zhang X; Fang J
    Gene; 2023 Jan; 851():146942. PubMed ID: 36202277
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Nutritional prevention of colorectal cancer.
    Hull MA
    Proc Nutr Soc; 2021 Feb; 80(1):59-64. PubMed ID: 32019626
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Identification of Key Genes and Signaling Pathways Associated with the Progression of gastric cancer.
    Yu C; Chen J; Ma J; Zang L; Dong F; Sun J; Zheng M
    Pathol Oncol Res; 2020 Jul; 26(3):1903-1919. PubMed ID: 31848941
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis.
    Li T; Gao X; Han L; Yu J; Li H
    World J Surg Oncol; 2018 Jun; 16(1):114. PubMed ID: 29921304
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The Role of Serum CK18, timp1, and MMP-9 Levels in Predicting R0 Resection in Patients with gastric cancer.
    Peduk S; Tatar C; Dincer M; Ozer B; Kocakusak A; Citlak G; Akinci M; Tuzun IS
    Dis Markers; 2018; 2018():5604702. PubMed ID: 29651326
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Identifying technology interaction opportunities within a gastroenterology exam room.
    Abrantes D; Pimentel-Nunes P; Dinis-Ribeiro M; Coimbra M
    Stud Health Technol Inform; 2015; 210():652-6. PubMed ID: 25991229
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Adenocarcinoma arising in gastric heterotopic pancreas. Case report and review of the literature.
    Lemaire J; Delaunoit T; Molle G
    Acta Chir Belg; 2014; 114(1):79-81. PubMed ID: 24720145
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Clinical utility of measuring expression levels of KAP1, timp1 and STC2 in peripheral blood of patients with gastric cancer.
    Wang YY; Li L; Zhao ZS; Wang HJ
    World J Surg Oncol; 2013 Apr; 11():81. PubMed ID: 23548070
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Levels of matrix metalloproteinase-1 and tissue inhibitors of metalloproteinase-1 in gastric cancer.
    Kemik O; Kemik AS; Sümer A; Dulger AC; Adas M; Begenik H; Hasirci I; Yilmaz O; Purisa S; Kisli E; Tuzun S; Kotan C
    World J Gastroenterol; 2011 Apr; 17(16):2109-12. PubMed ID: 21547130
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Clinical significance of serum levels of matrix metalloproteinase 2 (MMP-2) and its tissue inhibitor (timp-2) in gastric cancer.
    Mroczko B; Lukaszewicz-Zając M; Gryko M; Kędra B; Szmitkowski M
    Folia Histochem Cytobiol; 2011; 49(1):125-31. PubMed ID: 21526499
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Pre-treatment serum and plasma levels of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (timp-1) in gastric cancer patients.
    Mroczko B; Groblewska M; Łukaszewicz-Zajac M; Bandurski R; Kedra B; Szmitkowski M
    Clin Chem Lab Med; 2009; 47(9):1133-9. PubMed ID: 19728856
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Serum timp-1 in gastric cancer patients: a potential prognostic biomarker.
    Wang CS; Wu TL; Tsao KC; Sun CF
    Ann Clin Lab Sci; 2006; 36(1):23-30. PubMed ID: 16501233
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Hypermethylation of the TPEF/HPP1 gene in primary and metastatic colorectal cancers.
    Ebert MP; Mooney SH; Tonnes-Priddy L; Lograsso J; Hoffmann J; Chen J; Röcken C; Schulz HU; Malfertheiner P; Lofton-Day C
    Neoplasia; 2005 Aug; 7(8):771-8. PubMed ID: 16207479
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [A multianalysis study on clinicopathologic factors related to lymph node metastasis in gastric cancer].
    Zhang S; Li L; Lin H
    Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):399-402. PubMed ID: 11810772
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Reduced expression of tissue inhibitor of metalloproteinase in nodal metastasis of stomach cancer.
    Ko BK; Cho HR; Choi DW; Nam CW; Park CJ; Kim GY; Kim SS; Woo YJ; Huh J; Kim MY
    J Korean Med Sci; 1998 Jun; 13(3):286-90. PubMed ID: 9681807
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.